US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

122.16

+3.252.74%

Volume:14.47K

Turnover:1.77M

Market Cap:103.84M

PE:- -

High:124.11

Open:120.74

Low:120.74

Close:118.91

52wk High:126.40

52wk Low:54.56

Shares:850.00K

Float Shares:850.00K

Volume Ratio:0.67

T/O Rate:1.70%

Dividend:0.32

Dividend Rate:0.26%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS

Erasca Appoints Charles Fuchs as President of R&D

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million

Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook

Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment

Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BIB/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":122.1591,"timestamp":1787342400000,"preClose":118.9059,"halted":0,"volume":14470,"delay":0,"changeRate":0.02735944978340009,"floatShares":850000,"shares":850000,"eps":0,"marketStatus":"Pre-Mkt","change":3.2532,"latestTime":"08-24 08:38:24 EDT","open":120.74,"high":124.11,"low":120.74,"amount":1773913.7644,"amplitude":0.028342,"askPrice":126.05,"askSize":119,"bidPrice":118.48,"bidSize":126,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":122.1591,"sharesOutstanding":1040000,"nav":118.8171,"aum":99806364,"dividendRate":0.0026,"bidAskSpread":0.002683,"postHourTrading":{"tag":"盘后","latestPrice":122.25,"preClose":122.1591,"latestTime":"19:30 EDT","volume":16,"amount":1957.9646,"timestamp":1787355004616,"change":0.0909,"changeRate":0.000744,"amplitude":0},"volumeRatio":0.6743154336203617,"impliedVol":0.4492,"impliedVolPercentile":0.552},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":850000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6743154336203617,"shares":850000,"dividePrice":0.3176,"high":124.11,"amplitude":0.028342,"preClose":118.9059,"low":120.74,"week52Low":54.5634,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":122.1591,"committee":0.028571,"eps":0,"divideRate":0.0026,"volume":14470,"delay":0,"ttmEps":0,"open":120.74,"prevYearClose":79.7794,"prevWeekClose":122.1591,"prevMonthClose":96.6087,"prevQuarterClose":100.74,"fiveDayClose":106.8706,"twentyDayClose":97.8824,"sixtyDayClose":83.0594},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658396419","title":"Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658396419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658396419?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:47","pubTimestamp":1786366034,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","VRTX","BK4585","LU1585245621.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","IE0002270589.USD","BBH","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","BIB","IE0002141913.USD","IDNA","LU2468319806.SGD","BK4532","TBXU","BK4139","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU2236285917.USD","IBBQ","LU0289739699.SGD","LU2417539215.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU2237438978.USD","LU2324357040.USD","LU0432979614.USD","IE00B2B36J28.USD","LU2362541273.HKD","PBE","SG9999013999.USD","SG9999001176.USD","GNMX","LU0256863811.USD","BK4567","IBB","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU2362541513.USD","LU1093756325.SGD","LU1778281490.HKD","IE0009355771.USD","LU1035775433.USD","LU0079474960.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935018","title":"Erasca Appoints Charles Fuchs as President of R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935018","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935018?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:07","pubTimestamp":1786363655,"startTime":"0","endTime":"0","summary":"Erasca appoints Charles Fuchs as president of R&DErasca named Charles S. Fuchs president of research and development, effective immediately.Fuchs most recently served as chief medical officer at Tubul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL46mF8m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","ERAS","BK4532","LU1037948541.HKD","LU1778281490.HKD","LU2210149790.SGD","BK4583","LU0889565916.HKD","LU1430594728.SGD","LU2210150020.SGD","BK4578","LU1585245621.USD","BIB","LU0861579265.USD","IBB","TMED","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0965509283.SGD","LU1061106388.HKD","BMED","LU0320765992.SGD","IBBQ","NDAQ","BK4585","SG9999015952.SGD","LU0965509101.SGD","BCDF","LU0289739699.SGD","LU0965509010.AUD","LU0114720955.EUR","LU2468319806.SGD","IE0002270589.USD","LU1934455863.HKD","BK4568","LU1037948897.HKD","LU1057294990.SGD","SG9999014021.USD","LU2087621335.USD","LU0122379950.USD","LU1839511570.USD","LU0058720904.USD","BBH","LU1571399168.USD","GILD","MEDI","LU1066051498.USD","IE00B3T34201.USD","TBXU","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270935","title":"Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:03","pubTimestamp":1786363413,"startTime":"0","endTime":"0","summary":"Sionna scraps genetic disorder drug program after trial setback; shares tankAug 10 (Reuters)-Sionna TherapeuticsSION.Osaid on Monday it would stop developing its experimental drug as an addition to st","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0058720904.USD","GNMX","BK4139","IDNA","IE00B19Z9P08.USD","LU1585245621.USD","IBB","IE00B19Z3B42.SGD","LU0061475181.USD","SION","LU2236285917.USD","IE00B4R5TH58.HKD","LU0256863811.USD","LU1674673428.USD","PBE","LU0823416689.USD","IE0002270589.USD","LU2324357040.USD","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4567","VRTX","IE00B894F039.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1674673691.USD","LU2362540622.SGD","SGXZ57979304.SGD","LU2417539215.USD","IE00B19Z3581.USD","BK4585","IBBQ","BBH","LU2456880835.USD","SG9999013999.USD","IE0009355771.USD","LU1035775433.USD","TBXU","LU0417517546.SGD","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU2362541273.HKD","SG9999001176.SGD","BIB","IE00B2B36J28.USD","BK4532","LU2362541513.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891989","title":"Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:33","pubTimestamp":1786350780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 0.9% to 5.05 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.7% and Amgen Inc. remained unchanged.Trading volume totaled 86.6 million shares, compared to the 50-day average of 101.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU1983299246.USD","BBH","BK1191","LU2242652126.USD","IBBQ","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4533","LU2242646821.SGD","AMGN","SG9999001440.SGD","BK1515","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","IBB","LU0868494617.USD","01177","BK4585","LU1057294990.SGD","LU2112291526.USD","PBE","BK1521","IE00BZ08YT58.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","IE00B2B36J28.USD","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP","LU0058720904.USD","LU2468319806.SGD","BK4588","LU0109394709.USD","BK4534","BK1589","BK4599","IE00BZ08YR35.GBP","LU1023059063.AUD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658042600","title":"Amgen Inc : HSBC Raises Target Price to $445 from $425","url":"https://stock-news.laohu8.com/highlight/detail?id=2658042600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658042600?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:30","pubTimestamp":1786343453,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44709K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1571399168.USD","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657402621","title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657402621","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657402621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:46","pubTimestamp":1786142807,"startTime":"0","endTime":"0","summary":"Amgen SVP, Chief Compliance Officer Nancy Grygiel sells 2,970 shares for $1.2 millionAmgen SVP and chief compliance officer Nancy A. Grygiel exercised stock options on Aug. 6, 2026, acquiring 2,970 co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL4RnJzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","BK4585","TBXU","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","LU1061106388.HKD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK4533","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621940","title":"Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621940?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:05","pubTimestamp":1786140332,"startTime":"0","endTime":"0","summary":"Michael Okunewitch, an analyst from Maxim Group, reiterated the Buy rating on Gilead Sciences. The associated price target remains the same with $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0965509010.AUD","BK4139","LU1061106388.HKD","LU1934455863.HKD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU1066051498.USD","LU1066053197.SGD","BK4550","LU0889565916.HKD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0823416689.USD","LU0861579265.USD","IE0002270589.USD","TMED","GILD","BIB","LU0882574055.USD","BMED","LU0320765992.SGD","LU0289739699.SGD","LU1037948897.HKD","LU1674673691.USD","LU1934455194.USD","SG9999015986.USD","IE00B19Z3581.USD","LU1057294990.SGD","IBBQ","BBH","LU1839511570.USD","LU2089984988.USD","LU2087621335.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015952.SGD","BK4532","TBXU","MEDI","BK4568","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657749626","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657749626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657749626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:36","pubTimestamp":1786134960,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.80% to $133.21 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.62% to 7,757.64 and the Dow Jones Industrial Average  rising 0.28% to 54,036.93.The stock's rise snapped a two-day losing streak.Gilead Sciences Inc. closed 15.31% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.88% to $259.24, Pfizer Inc.  rose 2.14% to $26.76, and Abbott Laboratories  fell 0.14% to $107.81.Trading volume  eclipsed its 50-day average volume of 8.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU2324357040.USD","SG9999015978.USD","LU1934455194.USD","LU1023059063.AUD","LU0122379950.USD","BK4578","IBB","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU0882574055.USD","LU0965509010.AUD","LU1066053197.SGD","LU0289739699.SGD","LU1674673428.USD","IE00B3T34201.USD","LU0234570918.USD","LU1934455863.HKD","BIB","SG9999015945.SGD","BMED","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1037948897.HKD","TMED","LU1839511570.USD","IBBQ","BBH","LU1430594728.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU1585245621.USD","TBXU","BK4583","LU1778281490.HKD","BK4139","BK4585","LU2468319806.SGD","BK4566","LU2089984988.USD","BK4568","LU0889565916.HKD","LU0965509101.SGD","LU1037948541.HKD","LU1057294990.SGD","LU1061106388.HKD","LU2112291526.USD","LU2087621335.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","BK4532","LU0058720904.USD","BK4550","LU1066051498.USD","IE00B19Z3581.USD","LU0861579265.USD","LU0965508806.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","SG9999015952.SGD","LU1934455277.USD","LU1571399168.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626282","title":"Moderna Inc. Stock Climbs 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626282?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:33","pubTimestamp":1786134780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 9.9% to $59.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.The stock's rise snapped a two-day losing streak.Moderna Inc. closed 30.9% short of its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $259.24, Pfizer Inc. rose 2.1% to $26.76, and Gilead Sciences Inc. rose 1.80% to $133.21.Trading volume totaled 6.8 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU1585245621.USD","BK4551","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0889565916.HKD","LU1061106388.HKD","GNOM","LU1066053197.SGD","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","MRNY","LU0114720955.EUR","WDNA","LU1430594728.SGD","BK4550","BK4501","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","TMED","LU2468319806.SGD","MEDI","LU0823416689.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1674673428.USD","LU1934455277.USD","GILD","LU2112291526.USD","BK4566","LGHT","LU0861579265.USD","MRNX","IE00BZ1G4Q59.USD","IDNA","LU1023059063.AUD","SG9999015978.USD","LU1066051498.USD","SG9999015952.SGD","MRNA","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657469640","title":"Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657469640","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657469640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:36","pubTimestamp":1786120560,"startTime":"0","endTime":"0","summary":"Replimune Group received Food and Drug Administration clearance for its experimental skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.Th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU1983299246.USD","IOVA","BK4534","LU1023059063.AUD","LU0237698245.USD","LU1323610961.USD","BMY","IE0002141913.USD","LU1585245621.USD","IBBQ","LU1868837136.USD","REPL","LU2468319806.SGD","LU0306806265.USD","PJP","IE00BSNM7G36.USD","LU1868836591.USD","BK4585","LU2133065610.SGD","LABU","LU0225284248.USD","LU0061475181.USD","LU0289739699.SGD","SG9999001440.SGD","LU1093756168.USD","BK4533","AMGN","LU1670711123.USD","LU2242646821.SGD","PBE","LU1883839398.USD","BK4007","LU0225771236.USD","LU2089984988.USD","LU1718418525.SGD","LU0114720955.EUR","IHE","BK4532","TBXU","LU1061106388.HKD","BBH","IBB","LU0868494617.USD","LU1093756325.SGD","LU1989771016.USD","LU0321505868.SGD","BIB","LU0306807586.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615971","title":"Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615971","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615971?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:30","pubTimestamp":1786091400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 3.3% to 5.10 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 25668.03.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 44% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 88.6 million shares, compared to the 50-day average of 101.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","HK0000165453.HKD","LU0320765992.SGD","BK4534","LU1023059063.AUD","BK1589","IE00BZ08YR35.GBP","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","IE00BZ08YT58.USD","BK1521","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","SG9999001440.SGD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK1515","PBE","BK1191","LU2089984988.USD","01177","TBXU","LU1061106388.HKD","BBH","IE00BZ08YS42.EUR","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682986","title":"Moderna Inc. Stock Sheds 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682986?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:35","pubTimestamp":1786048500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.3% to $53.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,348.35 and Dow Jones Industrial Average falling 0.9% to 53,885.10.This was the stock's second consecutive day of losses.Moderna Inc. closed 37.1% short of its 52-week high of $85.60, which the company reached on July 6th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $256.98, Pfizer Inc. rose 1.5% to $26.20, and Gilead Sciences Inc. fell 0.68% to $130.86.Trading volume totaled 5.5 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LGHT","LU0823416689.USD","BK4583","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD","IE00B3T34201.USD","LU2112291526.USD","MRNX","BK4548","BK4568","IE00B19Z3B42.SGD","BK4551","LU1674673691.USD","BIB","LU1066053197.SGD","IBBQ","LU1934455194.USD","BBH","LU2087621335.USD","MRNY","LU1934455863.HKD","LU1037948897.HKD","BK4566","GNOM","MRNA","LU1037948541.HKD","WDNA","LU0058720904.USD","LU1061106388.HKD","BK4532","SG9999015945.SGD","IE00B19Z3581.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","BK4578","TBXU","IDNA","BK4585","IBB","BMED","BK4139","BK4533","BK4501","LU0965509010.AUD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567836","title":"Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:59","pubTimestamp":1786035577,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) just unveiled an announcement. Vortex Energy Corp. reported final results from a technical study by Lonquist Fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","LU2324357040.USD","LU2456880835.USD","LU1674673428.USD","LU2417539215.USD","BK4567","SG9999001176.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU1778281490.HKD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU1430594728.SGD","BK4585","LU2462157665.USD","LU0061475181.USD","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1069344957.HKD","LU2362540622.SGD","LU0889565916.HKD","IDNA","LU1093756168.USD","LU2362541513.USD","VRTX","IE00BJJMRZ35.SGD","PBE","IE00B894F039.SGD","LU2089984988.USD","BK4532","LU0417517546.SGD","SGXZ57979304.SGD","TBXU","BBH","LU1035775433.USD","LU2237438978.USD","BK4139","SG9999013999.USD","IBB","IE00BJT1NW94.SGD","LU2362541273.HKD","IE00B19Z3B42.SGD","GNMX","LU0256863811.USD","LU0109394709.USD","SG9999001176.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657585496","title":"Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2657585496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657585496?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:46","pubTimestamp":1786027560,"startTime":"0","endTime":"0","summary":"DJ Salesforce, UnitedHealth Share Losses Contribute To Dow's Nearly 150-Point DropThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Salesforce and UnitedHealth are seeing declines Thursday morning, dragging the Dow Jones Industrial Average into negative territory.Shares of Salesforce  and UnitedHealth  have contributed to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 144 points lower .Salesforce's shares have fallen $6.53  while those of UnitedHealth have declined $6.27, or 1.5%, combining for a roughly 76-point drag on the Dow.Also contributing significantly to the decline are Boeing , Honeywell , and Amgen .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","SG9999014898.SGD","LU0889565833.HKD","LU1988902786.USD","LU0211327993.USD","LU1674673691.USD","LU0109392836.USD","BK4154","IE0004445015.USD","LU0557290698.USD","TMED","LU1066051498.USD","BK4607","LU2247934214.USD","IE00BZ1G4Q59.USD","LU0342679015.USD","LU0868494708.USD","SG9999001176.SGD","LU0310800379.SGD","LU0162691827.USD","LU1791710400.SGD","IXJ","LU0795875169.SGD","BIB","BK4602","MISL","LU0109394709.USD","LU0648000940.SGD","LU2999663052.SGD","SG9999014880.SGD","BK4579","BOED","LU2125154778.USD","LU1261432733.SGD","JDOC","PJP","IE00BJT1NW94.SGD","LU0689626769.HKD","LU1720051108.HKD","LU0097036916.USD","BK4581","LU2324357040.USD","LU1069347547.HKD","BK4206","HON","IE00BFXG1179.USD","LU0058720904.USD","LU0079474960.USD","LU0211328371.USD","BOEU","LU0289739343.SGD","IHF","LU0072461881.USD","LU2211815571.USD","LU1914381329.SGD","LU0238689110.USD","UNHU","LU1064131342.USD","LU1267930490.SGD","04332","BK4543","IE00B19Z3B42.SGD","BK4551","IE00BJTD4N35.SGD","LU1119994496.HKD","LU0965509283.SGD","LU1023059063.AUD","IE00BKPKM429.USD","LU2028103732.USD","LU0158827781.USD","IE00B19Z8X17.USD","LU2360032135.SGD","LU0683600562.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2326559502.SGD","SGXZ81514606.USD","LU0149725797.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU2089284900.SGD","LU0077335932.USD","LU1057294990.SGD","AMGN","LU2362540622.SGD","LU1074936037.SGD","TRUH","LU0053666078.USD","LU0820562030.AUD","LU0234570918.USD","LU0354030438.USD","LU0943347566.SGD","LU1791710582.SGD","LU0354030511.USD","LU0477156953.USD","SG9999014906.USD","LU1854104046.USD","BK4613","LU0011850046.USD","LU1989764748.USD","IE00BQXX3D17.EUR","LU0528227936.USD","BK4532","LU0048573561.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU2552382132.HKD","LU1670627923.USD","LU0128525689.USD","LU0082616367.USD","SG9999001176.USD","LU1267930227.SGD","LU0496365809.HKD","LU0107464264.USD","LU0310800965.SGD","LU0316494557.USD","IE00B2B36J28.USD","LU1951198990.SGD","LU1670628061.USD","LU2242646821.SGD","LU1548497426.USD","LU2244417387.USD","IE00B19Z8W00.USD","RXL","IE000M9KFDE8.USD","IE00BWXC8680.SGD","LU1084165304.USD","BK4585","LU1571399168.USD","IE0005OL40V9.USD","LU1814569148.SGD","LU0266013472.USD","IE00B1BXHZ80.USD","LU1989764664.SGD","LU0949170772.SGD","BK4598","LU0820561909.HKD","LU0708995401.HKD","VHT","LU0251131958.USD","IE00BJJMRY28.SGD","LU2264538146.SGD","LU1496350502.SGD","LU1366333091.USD","ITA","LU2461242641.AUD","SG9999002232.USD","IBBQ","LU2458330169.SGD","LU2361044865.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0719512351.SGD","IDEF","LU0432979614.USD","BK4505","IE00B775H168.HKD","LU1435385759.SGD","LU2286300806.USD","LU0353189763.USD","LU1778281490.HKD","LU0130518102.USD","CRMG","LU2362541513.USD","LU1989771016.USD","LU0081259029.USD","LU0553294199.USD","IE00BKVL7J92.USD","LU2265009873.SGD","LU1003077747.HKD","IE00B19Z9P08.USD","LU0320765059.SGD","LU0672654240.SGD","LU0158827948.USD","IBB","SG9999017495.SGD","BA","LU0006306889.USD","LU0942090050.USD","MHIP","BK4548","BK4187","LU0234572021.USD","LU0114720955.EUR","LU0472753341.HKD","SGXZ99366536.SGD","LU0648001328.SGD","LU0417517546.SGD","LU1854103824.USD","BK4527","BBH","LU0738911758.USD","BK4023","IE00B1XK9C88.USD","LU1046421795.USD","IE00BN29S564.USD","PPA","IE0034235188.USD","LU1267930730.SGD","LU0353189680.USD","LU2357305700.SGD","LU1291159041.SGD","LU1201861249.SGD","SG9999001440.SGD","LU0052756011.USD","LU1732800096.USD","LU1316542783.SGD","BK4533","LU0198837287.USD","LU1674673428.USD","LU1718418525.SGD","IE00B4JS1V06.HKD","LU2242649171.HKD","LU0251132253.USD","LU2089984988.USD","IYH","LU0820561818.USD","LU2491050154.USD","IE00BQXX3C00.GBP","LU1323610961.USD","SG9999018857.SGD","LU2552382215.SGD","IE00B894F039.SGD","UNHG","LU0251142724.SGD","LU0289961442.SGD","LU0792757196.USD","LU2954938101.SGD","LU1923623000.USD","LU0310799852.SGD","LU0187121727.USD","SG9999002224.SGD","LU0256863811.USD","LU0477156797.USD","LU0795875086.SGD","IE00B19Z3581.USD","LU0314104364.USD","LU0661504455.SGD","LU0057025933.USD","LU2462591277.SGD","LU0211326755.USD","LU2133065610.SGD","LU0787776722.HKD","LU0965509101.SGD","IE00BFSS7M15.SGD","LU1037948897.HKD","LU0511384066.AUD","CRM","LU1066051811.HKD","SGXZ51526630.SGD","LU0320765992.SGD","LU2087625088.SGD","LU1267930573.SGD","IE0002141913.USD","LU2112291526.USD","LU0545039389.USD","LU0823416689.USD","IE00BQXX3F31.USD","SG9999018865.SGD","LU1823568750.SGD","LU2458330243.SGD","BK4535","BK4608","LU0127658192.USD","LU2756315318.SGD","LU1066051225.USD","LU1551013425.SGD","LU0642271901.SGD","LU2279689827.SGD","FHLC","LU0980610538.SGD","LU1934455863.HKD","NATO","BK4516","LU1235294995.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU1551013342.USD","BK4538","LU2236285917.USD","IE00BJJMRX11.SGD","LU1153585028.USD","LU0109391861.USD","UNH","BK4567","FOWF","SG9999014914.USD","LU1934455277.USD","LU0124676726.USD","LU0456855351.SGD","LU0912757837.SGD","LU0742534661.SGD","SG9999013999.USD","TBXU","LU0106261372.USD","LU2242652126.USD","LU1506573853.SGD","PBE","LU0029864427.USD","LU2362541273.HKD","IE00B7KXQ091.USD","LU0143551892.USD","LU1201861165.SGD","LU2125154935.USD","LU1804176565.USD","IE00B19Z9505.USD","GDOC","LU0130517989.USD","LU0128525929.USD","LU0211326839.USD","LU2347655156.SGD","LU0048584097.USD","LU0267386448.USD","LU2023251221.USD","LU1061106388.HKD","IE00B19Z9Z06.USD","LU0094547139.USD","LU1496350171.SGD","BK4528","UNHW","LU0289739699.SGD","LU1720051017.SGD","LU2271345857.HKD","BOEG","LU0708994859.HKD","LU0122379950.USD","BK4564","HRTS","LU1803068979.SGD","LU0861579265.USD","LU0689472784.USD","LU0965509010.AUD","LU0203345920.USD","LU1732799900.SGD","IE0004445239.USD","LU2468319806.SGD","LU1951200564.SGD","LU1429558221.USD","BK4534","LU0345770308.USD","LU1037948541.HKD","LU0965508806.USD","IE00BZ9MQY76.HKD","IE00BJTD4V19.USD","LU0889566641.SGD","LU0345770993.USD","LU2361044949.HKD","LU2361045086.USD","LU0157215616.USD","LU2552382058.USD","LU0889565916.HKD","LU0976567544.SGD","LU1934455194.USD","LU2491050071.SGD","LU0868494617.USD","IE0009355771.USD","LU0069063385.USD","BK4139","BK4588","IE0002270589.USD","LU1267930813.SGD","LU0130102774.USD","LU1983299246.USD","BK4550","BK4566","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","XLV","LU0882574055.USD","BK4561","IE00BSNM7G36.USD","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682336","title":"Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682336","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682336?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:11","pubTimestamp":1786011111,"startTime":"0","endTime":"0","summary":"Generate Biomedicines Q2 FY26 net loss widens to $67.26 million; revenue drops to $6.31 millionGenerate Biomedicines posted a GAAP net loss of $67.26 million for the quarter ended June 30, 2026, widen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8LfD7q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1571399168.USD","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","BK4599","BBH","LU0868494617.USD","LU0058720904.USD","GENB","LU2468319806.SGD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","IBB","IBBQ","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657357543","title":"Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657357543","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657357543?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:53","pubTimestamp":1785963209,"startTime":"0","endTime":"0","summary":"Exelixis Q2 revenue misses analyst estimates, lowers 2026 outlookOverviewU.S. oncology firm's Q2 revenue rose yr/yr but missed analyst expectationsAdjusted net income for Q2 beat analyst estimatesComp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","BK4532","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","URGN","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578623","title":"Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578623","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578623?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961240,"startTime":"0","endTime":"0","summary":"Vir Biotechnology Q2 revenue up, beats estimates on Astellas paymentOverviewU.S. biopharma's Q2 revenue rose sharply, beating analyst expectationsQ2 net income was $80.1 mln, reversing a net loss last","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU2324357040.USD","LU1674673691.USD","LU0058720904.USD","SG9999015945.SGD","KYMR","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU0861579265.USD","LU2087621335.USD","LU0882574055.USD","BK4599","BK4535","PJP","MEDI","IE00BSNM7G36.USD","LU1430594728.SGD","BK4550","VIR","LU1934455863.HKD","LU0289739699.SGD","LU1057294990.SGD","LU1066051498.USD","LU0889565916.HKD","LU0823416689.USD","SG9999015978.USD","AMGN","IE00BJJMRZ35.SGD","BMED","PBE","BK4568","LU0114720955.EUR","BK4532","TBXU","LU1061106388.HKD","BBH","IE00BJT1NW94.SGD","IBB","GILD","IE00B19Z3B42.SGD","LU0868494617.USD","LU0965509101.SGD","TMED","LU0234570918.USD","LU1839511570.USD","BIB","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657224905","title":"Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2657224905","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657224905?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:36","pubTimestamp":1785958615,"startTime":"0","endTime":"0","summary":"Gilead Sciences declares Q3 2026 distribution of R$ 1.42 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 cash distribution of R$ 1.42 per unit for ISIN BRGILDBDR000.Shares trade with entitlement t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL34j8pX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","GILD","BIB","LU0109394709.USD","IE00BSNM7G36.USD","LU1037948541.HKD","BK4583","LU1674673428.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","SG9999015978.USD","LU0320765992.SGD","LU2112291526.USD","IE0002270589.USD","LU0882574055.USD","LU0965509101.SGD","LU1057294990.SGD","LU0889565916.HKD","BK4566","IE00B3T34201.USD","SG9999015952.SGD","LU0289739699.SGD","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU2089984988.USD","LU1674673691.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4568","BK4532","LU1037948897.HKD","LU1585245621.USD","BBH","LU2468319806.SGD","LU0965509283.SGD","IBB","LU0122379950.USD","BMED","TMED","TBXU","LU1778281490.HKD","LU1061106388.HKD","LU0114720955.EUR","LU1839511570.USD","SG9999015986.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524750","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657524750?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:30","pubTimestamp":1785954614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB) wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","IDNA","IE00B19Z9P08.USD","LU0079474960.USD","LU1585245621.USD","IBB","IE00B19Z3B42.SGD","LU0109394709.USD","LU0061475181.USD","LU0889565916.HKD","LU0256863811.USD","LU1430594728.SGD","PBE","LU0823416689.USD","LU2362541513.USD","SG9999001176.USD","BK4023","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","QTTB","XBI","VERX","VRTX","LU0289739699.SGD","SGXZ57979304.SGD","LU2468319806.SGD","LU2417539215.USD","IE00B19Z3581.USD","LABU","IBBQ","LU1093756168.USD","BBH","LU2089984988.USD","LU1815336091.USD","BK4581","LU0029874061.USD","XLV","HCSG","TBXU","LU0417517546.SGD","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU2362541273.HKD","SG9999001176.SGD","BIB","IE00B2B36J28.USD","BK4532","LU1093756325.SGD","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521560","title":"Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521560","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521560?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:17","pubTimestamp":1785950227,"startTime":"0","endTime":"0","summary":"Gilead Sciences  offered \"plenty\" to like in Q2, with strong HIV performance more than offsetting slower franchises, RBC said in a note Tuesday.The report said it should be well received that the higher HIV growth guidance helped drive the incremental full-year product sales guidance raise, reflecting expectations for steadying volume dynamics and favorable pricing pull through.Still, the note pointed to some modest long-term headwinds, including the Inflation Reduction Act and a more fragmented HIV market with more switch options.But its strong operational performance sets a higher base into any potential erosion, and the company has multiple shots to continue dominance, the note added.The report said sentiment may lean positive and keep shares at optimistic levels as its near-term performance is expected to remain solid amid \"palatable\" forward multiple.RBC raised its price target to $123 from $120 while maintaining its sector perform rating.Price: 130.80, Change: -4.45, Percent Chan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU0114720955.EUR","MEDI","IE00B3T34201.USD","LU0320765992.SGD","IE00BSNM7G36.USD","BK4585","LU1674673428.USD","BIB","LU0965509283.SGD","SG9999015986.USD","TBXU","LU1066053197.SGD","LU1066051498.USD","BK4550","LU0861579265.USD","IE00BKVL7J92.USD","LU1585245621.USD","LU1037948541.HKD","BMED","LU1571399168.USD","LU1061106388.HKD","IBB","BBH","IE00B19Z3581.USD","LU1023059063.AUD","LU1037948897.HKD","LU0889565916.HKD","LU1778281490.HKD","LU2112291526.USD","LU0109394709.USD","LU0058720904.USD","BK4139","LU2087621335.USD","LU0823416689.USD","SG9999015945.SGD","SG9999015978.USD","IE0002270589.USD","LU0965508806.USD","GILD","TMED","BK4578","LU1934455277.USD","LU2089984988.USD","IE00B7SZLL34.SGD","IBBQ","LU1057294990.SGD","LU0965509010.AUD","LU0289739699.SGD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}